Retatrutide, with triple-target effects (it works at the two receptors mentioned above and the glucagon receptor), caused people to lose about a quarter of their body weight after a year in a Phase II study (Jastreboff AM et al, N Engl J Med 2023;389(6):514526), although a follow-up study found the weight loss more in line with tirzepatide
Its a healthy chip dip or a great toast spread
An in-depth understanding of the causal relationships between various metabolites and epilepsy and an exploration of related mechanisms may provide new targets for epilepsy screening and prevention
Melissa Ilardo My guest is Dr
Improved Blood Sugar Control: Beneficial for weight management and overall health, particularly for those with type 2 diabetes
Claims with weak, preliminary, preclinical, or unsupported evidence are identified as such rather than presented as established medical benefit